Alivus Life Sciences Limited (NSE:ALIVUS)
India
· Delayed Price · Currency is INR 927.40
-7.40 (-0.79%)
At close: Aug 11, 2025, 3:30 PM IST
Alivus Life Sciences Revenue
Alivus Life Sciences had revenue of 6.02B INR in the quarter ending June 30, 2025, with 2.25% growth. This brings the company's revenue in the last twelve months to 24.00B, up 4.65% year-over-year. In the fiscal year ending March 31, 2025, Alivus Life Sciences had annual revenue of 23.87B with 4.54% growth.
Revenue (ttm)
24.00B
Revenue Growth
+4.65%
P/S Ratio
4.90
Revenue / Employee
10.89M
Employees
2,014
Market Cap
117.58B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 537.77B |
| Divi's Laboratories | 96.52B |
| Cipla | 274.80B |
| Apollo Hospitals Enterprise | 217.94B |
| Mankind Pharma | 129.10B |
| Zydus Lifesciences | 236.99B |
| Fortis Healthcare | 80.94B |
| Aurobindo Pharma | 320.25B |